{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:33:09Z","timestamp":1787772789650,"version":"build-2784847793"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Human Cytomegalovirus (HCMV) gH\/gL\/UL128\/UL130\/UL131A complex (Pentamer) is among the candidates for the development of a vaccine against HCMV; indeed, it brought to more immunogenic formulations which were able to protect the fetus against vertical transmission in pregnant women. Pentamer-specific antibodies have shown to be hundredfold more potent than gB or gH\/gL antibodies, endowed with strong neutralizing activity. The often inadequate antibody immune response elicited by glycoprotein antigen has been, in part, attributed to the abundance of glycosylation on the protein. Here, we determine the composite glycan population of each of the N-linked and O-linked glycosylation sites present on the Pentamer by multienzymatic proteolysis and mass spectrometry; furthermore, total N-glycans profiles of Pentamer expressed in different cell systems have been compared exploiting the glycan fluorescent labeling and the immunogenicity of Pentamer with different glycosylation patterns has been investigated. Our analysis reveals the presence of underprocessed oligomannose-type glycans on some glycosylation sequons, which are probably derived as a result of sterically reduced accessibility to glycan processing enzymes. Furthermore, the antigen glycosylation pattern affects the elicitation of neutralizing antibodies in mice.<\/jats:p>","DOI":"10.1093\/glycob\/cwag062","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:49:40Z","timestamp":1785930580000},"source":"Crossref","is-referenced-by-count":0,"title":["Site-specific and global glycan analysis of the human cytomegalovirus pentameric glycoprotein by high resolution mass spectrometry"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9091-1411","authenticated-orcid":false,"given":"Antonio","family":"Lembo","sequence":"first","affiliation":[{"name":"Department of Chemical Sciences, University of Naples Federico II , Via Vicinale Cupa Cintia, 26, 80126 Naples ,","place":["Italy"]},{"name":"GSK Vaccines, Analytical R&D , Via Fiorentina, 1, 53100, Siena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Sardone","sequence":"additional","affiliation":[{"name":"GSK Vaccines, Analytical R&D , Via Fiorentina, 1, 53100, Siena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Aurilia","sequence":"additional","affiliation":[{"name":"GSK Vaccines, Analytical R&D , Via Fiorentina, 1, 53100, Siena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-7450","authenticated-orcid":false,"given":"Immacolata","family":"Speciale","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, University of Naples Federico II , Via Vicinale Cupa Cintia, 26, 80126 Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-1756","authenticated-orcid":false,"given":"Cristina","family":"De Castro","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, University of Naples Federico II , Via Vicinale Cupa Cintia, 26, 80126 Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Biagini","sequence":"additional","affiliation":[{"name":"GSK Vaccines, Analytical R&D , Via Fiorentina, 1, 53100, Siena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"32","key":"2026082615064667600_ref1","doi-asserted-by":"crossref","first-page":"21473","DOI":"10.1074\/jbc.M115.637363","article-title":"Mucin-like region of herpes simplex virus type 1 attachment protein glycoprotein C (gC) modulates the virus-glycosaminoglycan interaction","volume":"290","author":"Altgarde","year":"2015","journal-title":"J Biol Chem"},{"issue":"5","key":"2026082615064667600_ref2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/rcm.2874","article-title":"A potential pitfall in 18O-based N-linked glycosylation site mapping","volume":"21","author":"Angel","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"23","key":"2026082615064667600_ref3","doi-asserted-by":"crossref","first-page":"12014","DOI":"10.1074\/jbc.M116.721746","article-title":"Global mapping of O-glycosylation of varicella zoster virus, human cytomegalovirus, and Epstein-Barr virus","volume":"291","author":"Bagdonaite","year":"2016","journal-title":"J Biol Chem"},{"issue":"11","key":"2026082615064667600_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2016.02.058","article-title":"Composition and antigenic effects of individual glycan sites of a trimeric HIV-1 envelope glycoprotein","volume":"14","author":"Behrens","year":"2016","journal-title":"Cell Rep"},{"key":"2026082615064667600_ref5","doi-asserted-by":"crossref","first-page":"14954","DOI":"10.1038\/ncomms14954","article-title":"Global site-specific N-glycosylation analysis of HIV envelope glycoprotein","volume":"8","author":"Cao","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"2026082615064667600_ref6","doi-asserted-by":"crossref","first-page":"eaan1457","DOI":"10.1126\/sciimmunol.aan1457","article-title":"Structural basis for potent antibody-mediated neutralization of human cytomegalovirus","volume":"2","author":"Chandramouli","year":"2017","journal-title":"Sci Immunol"},{"issue":"16","key":"2026082615064667600_ref7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1073\/pnas.1424818112","article-title":"Structural and biochemical studies of HCMV gH\/gL\/gO and pentamer reveal mutually exclusive cell entry complexes","volume":"112","author":"Ciferri","year":"2015","journal-title":"PNAS."},{"issue":"10","key":"2026082615064667600_ref8","doi-asserted-by":"crossref","first-page":"e1005230","DOI":"10.1371\/journal.ppat.1005230","article-title":"Antigenic characterization of the HCMV gH\/gL\/gO and pentamer cell entry complexes reveals binding sites for potently neutralizing human antibodies","volume":"11","author":"Ciferri","year":"2015","journal-title":"PLoS Pathog"},{"issue":"9","key":"2026082615064667600_ref9","first-page":"1062","article-title":"Robustness and repeatability of GlycoWorks RapiFluor-MS IgG N-glycan profiling in a long-term high-throughput glycomic study","volume":"31","author":"Deris","year":"2021","journal-title":"Glycobiology."},{"issue":"5446","key":"2026082615064667600_ref10","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1126\/science.286.5446.1882","article-title":"Setting the standards: quality control in the secretory pathway","volume":"286","author":"Ellgaard","year":"1999","journal-title":"Science"},{"issue":"2","key":"2026082615064667600_ref11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J Pathol"},{"issue":"10","key":"2026082615064667600_ref12","doi-asserted-by":"crossref","first-page":"O111.009381","DOI":"10.1074\/mcp.O111.009381","article-title":"Detection, evaluation and minimization of nonenzymatic deamidation in proteomic sample preparation","volume":"10","author":"Hao","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"2026082615064667600_ref13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0006-3495(01)76074-2","article-title":"Database analysis of O-glycosylation sites in proteins","volume":"80","author":"Hema Thanka Christlet","year":"2001","journal-title":"Biophys J"},{"issue":"10","key":"2026082615064667600_ref14","doi-asserted-by":"crossref","first-page":"eabm2536","DOI":"10.1126\/sciadv.abm2536","article-title":"Structural basis for HCMV pentamer receptor recognition and antibody neutralization","volume":"8","author":"Kschonsak","year":"2022","journal-title":"Science Advences"},{"key":"2026082615064667600_ref15","doi-asserted-by":"crossref","first-page":"109838","DOI":"10.1016\/j.carres.2026.109838","article-title":"Dissecting the glycoprofile of the human cytomegalovirus protein gB by comprehensive mass spectrometry analysis","volume":"562","author":"Lembo","year":"2026","journal-title":"Carbohydr Res"},{"issue":"26","key":"2026082615064667600_ref16","doi-asserted-by":"crossref","first-page":"15985","DOI":"10.1074\/jbc.M115.652230","article-title":"Soluble human cytomegalovirus gH\/gL\/pUL128\u2013131 pentameric complex, but not gH\/gL, inhibits viral entry to epithelial cells and presents dominant native neutralizing epitopes","volume":"290","author":"Loughney","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"2026082615064667600_ref17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"2026082615064667600_ref18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cell.2018.06.028","article-title":"An unbiased screen for human cytomegalovirus identifies Neuropilin-2 as a central viral receptor","volume":"174","author":"Martinez-Martin","year":"2018","journal-title":"Cell."},{"issue":"5","key":"2026082615064667600_ref19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.sbi.2006.08.005","article-title":"N-linked glycan recognition and processing: the molecular basis of endoplasmic reticulum quality control","volume":"16","author":"Moremen","year":"2006","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"2026082615064667600_ref20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-virology-111821-121007","article-title":"Structure and role of O-linked glycans in viral envelope proteins","volume":"10","author":"Olofsson","year":"2023","journal-title":"Annual Review ofVirology"},{"issue":"6","key":"2026082615064667600_ref21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/jps.23529","article-title":"Asparagine deamidation dependence on buffer type, pH, and temperature","volume":"102","author":"Pace","year":"2013","journal-title":"J Pharm Sci"},{"issue":"43","key":"2026082615064667600_ref22","doi-asserted-by":"crossref","first-page":"e2404892121","DOI":"10.1073\/pnas.2404892121","article-title":"The accomplices: heparan sulfates and N- glycans foster SARS- CoV- 2 spike:ACE2 receptor binding and virus priming","volume":"121","author":"Paiardi","year":"2024","journal-title":"PNAS."},{"issue":"50","key":"2026082615064667600_ref23","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","volume":"37","author":"Plotkin","year":"2019","journal-title":"Vaccine."},{"issue":"6","key":"2026082615064667600_ref24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jasms.2009.01.013","article-title":"Label-free quantitation: a new glycoproteomics approach","volume":"20","author":"Rebecchi","year":"2009","journal-title":"J Am Soc Mass Spectrom"},{"key":"2026082615064667600_ref25","doi-asserted-by":"crossref","first-page":"108206","DOI":"10.1016\/j.biotechadv.2023.108206","article-title":"Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies","volume":"67","author":"Rocamora","year":"2023","journal-title":"Biotechnol Adv"},{"issue":"1","key":"2026082615064667600_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409239709085144","article-title":"Glycosylation: heterogeneity and the 3D structure of proteins","volume":"32","author":"Rudd","year":"1997","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"6","key":"2026082615064667600_ref27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/vaccines9060551","article-title":"Development of a vaccine against human cytomegalovirus: advances, barriers, and implications for the clinical practice","volume":"9","author":"Scarpini","year":"2021","journal-title":"Vaccines"},{"issue":"6","key":"2026082615064667600_ref28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jms.3210","article-title":"Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides","volume":"48","author":"Stavenhagen","year":"2013","journal-title":"J Mass Spectrom"},{"issue":"1","key":"2026082615064667600_ref29","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1038\/s41467-023-39699-5","article-title":"Glycopeptide database search and de novo sequencing with PEAKS GlycanFinder enable highly sensitive glycoproteomics","volume":"14","author":"Sun","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"2026082615064667600_ref30","first-page":"1296","article-title":"Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries","volume":"187","author":"Tsai","year":"2024","journal-title":"Cell Press"},{"issue":"12","key":"2026082615064667600_ref31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/glycob\/cwv091","article-title":"Symbol nomenclature for graphical representations of glycans","volume":"25","author":"Varki","year":"2015","journal-title":"Glycobiology."},{"issue":"4","key":"2026082615064667600_ref32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/glycob\/cwl086","article-title":"Comparison of the methods for profiling glycoprotein glycans--HUPO human disease Glycomics\/proteome initiative multi-institutional study","volume":"17","author":"Wada","year":"2007","journal-title":"Glycobiology."},{"issue":"6501","key":"2026082615064667600_ref33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science."},{"issue":"10","key":"2026082615064667600_ref34","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1021\/acs.jproteome.0c00435","article-title":"Current methods for the characterization of O-glycans","volume":"19","author":"Wilkinson","year":"2020","journal-title":"J Proteome Res"},{"issue":"9","key":"2026082615064667600_ref35","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s13361-017-1701-4","article-title":"Electron-transfer\/higher-energy collision dissociation (EThcD)-enabled intact glycopeptide\/glycoproteome characterization","volume":"28","author":"Yu","year":"2017","journal-title":"J Am Soc Mass Spectrom"},{"issue":"17","key":"2026082615064667600_ref36","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1128\/JVI.01325-15","article-title":"Human cytomegalovirus gH\/gL\/gO promotes the fusion step of entry into all cell types, whereas gH\/gL\/UL128-131 broadens virus tropism through a distinct mechanism","volume":"89","author":"Zhou","year":"2015","journal-title":"J Virol"}],"container-title":["Glycobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/glycob\/advance-article-pdf\/doi\/10.1093\/glycob\/cwag062\/70496851\/cwag062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/glycob\/article-pdf\/36\/10\/cwag062\/70496851\/cwag062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/glycob\/article-pdf\/36\/10\/cwag062\/70496851\/cwag062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:12:37Z","timestamp":1787771557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/glycob\/article\/doi\/10.1093\/glycob\/cwag062\/8752690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8,23]]}},"URL":"https:\/\/doi.org\/10.1093\/glycob\/cwag062","relation":{},"ISSN":["1460-2423"],"issn-type":[{"value":"1460-2423","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,5]]},"article-number":"cwag062"}}